Support ongoing work for small molecule and combination screening, in silicon virtual screening, nanobody/antibody design, and optimization that are part of ncats's ongoing work to support the…
Ended Purchase Order Awarded
- Contract number
- 75N95022P00273
- Awardee
-
Beckman Coulter, Inc. UEI Z4DRFM3LMJB8 Part of Danaher Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,026,792
Award facts
- Opportunity
-
- Beckman Coulter Access System for Acoustic Dispensing Systems with Accessories OR EQUAL Solicitation · 75N95022Q00162 · Posted Mar 31, 2022
- Contract value 100% obligated
- $1,026,792.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Brea, CA 92821, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health National Institute on Drug Abuse awarded a $1,026,792 firm fixed price purchase order to Beckman Coulter Inc. to support ongoing SARS-CoV-2 screening efforts. The solicitation sought a Beckman Coulter Access System for Acoustic Dispensing Systems with accessories to equip NIDA's newly established Biosafety Level 3 laboratory. There was no set-aside designation. Funding comes from the Department of Health and Human Services through NIH and NIDA, and work will be performed in Brea, California through May 2023. This procurement supports NIDA's pandemic response efforts through small molecule and combination screening, virtual screening, nanobody design, and related optimization activities.
Description
Support ongoing work for small molecule and combination screening, in silicon virtual screening, nanobody/antibody design, and optimization that are part of ncats's ongoing work to support the pandemic response.
Quick answers
Who was awarded contract 75N95022P00273?
75N95022P00273 was awarded to Beckman Coulter, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 23, 2022.
How much is contract 75N95022P00273 worth?
The government has obligated $1,026,792 on 75N95022P00273.
Was contract 75N95022P00273 competed?
The extent of competition for 75N95022P00273 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award